yep, was a bad one for sanofi. off-patent blockbusters losing...

yep, was a bad one for sanofi. off-patent blockbusters losing sales fast.

this may be good, but may be bad for us:

a) you think they would try and keep sales high and outdo the competition by introducing better unilife injectibles with the approved product? that would be good for us in the short term.

b) but maybe they think its time to cut costs, accept terminal decline and focus on their growth platforms? all the while delaying the unifill for later pipeline products. not so good in the short term.

dont know, just thinking aloud. if sanofi was the unknown pharma, i was hoping yesterday was the day for uns and the results release would coincide with the supply agreement. but nothing mentioned by either party. maybe an announcement in oz today? maybe not, fridays are usually flat.